(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ Composite: ARCT) jumped 5.33% to $47.62 at 12:19 EST on Thursday, after two successive sessions in a row of gains. NASDAQ Composite is rising 1.63% to $14,809.47, following the last session’s upward trend. This seems, at the moment, an all-around up trend trading session today.
Arcturus Therapeutics’s last close was $45.21, 65.15% below its 52-week high of $129.71.
Today’s last reported volume for Arcturus Therapeutics is 157761 which is 81.49% below its average volume of 852609.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 625.3% for the current quarter and 1814.2% for the next. The company’s growth estimates for the ongoing quarter is a negative 72.8% and positive 6.4% for the next.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a negative 0.20%, a negative 1.78%, and a positive 5.65%, respectively.
Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.76% (last week), 4.02% (last month), and 5.65% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be oversold (<=20).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $47.62 at 12:19 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s worth is below its 50-day moving average of $50.56 and way above its 200-day moving average of $39.62.
More news about Arcturus Therapeutics (ARCT).